Incyte Corporation News
Avita Medical May Be the Hidden Gem of Biotech Stocks
Avita Medical expects a big second half. Will that set the stage for a multiyear growth runway?
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.
Cramer's Mad Money Recap 12/21: Micron Technology, Apple, Amazon, AMD
Jim Cramer says investors may fret about politics and interest rates, but stocks trade on their own merits.
Qualcomm, Fedex Make BofA List of Potential Tax Beneficiaries
Bank of America identifies 13 stocks that may suffer from tax-loss selling through Oct. 31 and then rebound afterward.
Incyte Drug Misses Endpoint in COVID-Respiratory-Distress Trial
Incyte's Phase 3 study of ruxolitinib missed its primary endpoint of preventing patient deaths from COVID-related acute respiratory distress syndrome.
'Mad Money' Lightning Round: Oracle, Zillow, Pfizer and more
Jim Cramer's bullish on Cognyte Software and Palo Alto Networks, but he says biopharmaceutical companies are under pressure.
Starbucks and Pepsi Make Wolfe List of Top Dividend Stocks
The S&P 500 Dividend Aristocrats index has slipped 6% year to date, compared with a 17% drop for the S&P 500.
Vietnamese Tesla Rival Sets Sail for the U.S. Market
VinFast is shipping 999 of its electric vehicles to California as the Vietnamese company looks for a place in the U.S. market.